c-kit(+) cells: the tell-tale heart of cardiac regeneration?

Area of Science:

• Regenerative Medicine
• Cardiology
• Stem Cell Biology

Background:

• Cardiovascular disease remains a leading cause of death globally.
• Current therapies manage symptoms but don't address cardiac tissue loss.
• Stem/progenitor cell therapy offers a promising avenue for cardiac repair and regeneration.

Purpose of the Study:

• To provide a comprehensive and critical evaluation of the literature on c-kit(+) cells.
• To address the true potential, benefits, and controversies surrounding c-kit(+) cell therapy for cardiac repair.
• To review the evidence from bench to bedside regarding c-kit(+) cell applications.

Main Methods:

• Literature review of preclinical and clinical studies on c-kit(+) cells.
• Critical analysis of the functional contribution of c-kit(+) cells to cardiomyocyte turnover.
• Evaluation of the regenerative potential, benefits, and controversies of c-kit(+) cell therapy.

Main Results:

• c-kit(+) cells are self-renewing, clonogenic, and multipotent, with potential to differentiate into cardiovascular lineages.
• Evidence suggests c-kit(+) cells can improve cardiac function, despite ongoing debate about their role in cardiomyocyte turnover.
• Numerous studies support the capacity of c-kit(+) cells for cardiac repair.

Conclusions:

• c-kit(+) cells represent a significant area of interest and debate in cardiac regeneration.
• Further research is needed to fully elucidate their functional contribution and optimize therapeutic applications.
• The review aims to provide an impartial assessment of c-kit(+) cells for clinical translation.